toripalimab subcutaneous (JS001sc) - Shanghai Junshi Bioscience
Keytruda (pembrolizumab) - Merck (MSD)
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
AiRuiKa (camrelizumab) - Elevar Therapeutics
Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/42698536
 
Fuhong Qin; Jianwei Ji; Mengmeng Teng; Qian Du; Ruikang Zhang; Yalin Dong
 
Sep 6, 2026
 
Prev Next